Results 151 to 160 of about 4,939 (180)
, 1961 Some of the next articles are maybe not open access.
Related searches:
Related searches:
Medical Clinics of North America, 1991
As clinical experience with patients with ZES has grown, increasing recognition has been made of the broad spectrum of symptoms associated with gastrinomas. Diarrhea and acid-induced esophageal injury have taken their place alongside chronic peptic ulcer disease as indications for screening for gastrinoma.
C L, Berg, M M, Wolfe
openaire +2 more sources
As clinical experience with patients with ZES has grown, increasing recognition has been made of the broad spectrum of symptoms associated with gastrinomas. Diarrhea and acid-induced esophageal injury have taken their place alongside chronic peptic ulcer disease as indications for screening for gastrinoma.
C L, Berg, M M, Wolfe
openaire +2 more sources
Current Treatment Options in Gastroenterology, 2003
Zollinger-Ellison syndrome (ZES) is caused by a gastrin-producing tumor called a gastrinoma, which results in gastric acid hypersecretion. Gastrin stimulates the parietal cell to secrete acid directly and indirectly by releasing histamine from enterochromaffin-like (ECL) cells, and induces hyperplasia of parietal and ECL cells.
Patrick D., Hung +2 more
openaire +2 more sources
Zollinger-Ellison syndrome (ZES) is caused by a gastrin-producing tumor called a gastrinoma, which results in gastric acid hypersecretion. Gastrin stimulates the parietal cell to secrete acid directly and indirectly by releasing histamine from enterochromaffin-like (ECL) cells, and induces hyperplasia of parietal and ECL cells.
Patrick D., Hung +2 more
openaire +2 more sources
The Lancet, 1964
Few clinical states have aroused more interest and curiosity among physicians than has the Zollinger-Ellison syndrome. In the eight years since its description in 1955, pathologists, physiologists, and clinicians have become very much aware of the intriguing relationship between endocrinopathy and peptic ulceration despite the fact that the syndrome is
openaire +4 more sources
Few clinical states have aroused more interest and curiosity among physicians than has the Zollinger-Ellison syndrome. In the eight years since its description in 1955, pathologists, physiologists, and clinicians have become very much aware of the intriguing relationship between endocrinopathy and peptic ulceration despite the fact that the syndrome is
openaire +4 more sources
The American Journal of Surgery, 1969
Abstract Zollinger-Ellison syndrome is caused by a neuroendocrine tumor of the pancreas that secretes gastrin, causing massive gastric acid secretion. Treatment of the acid hypersecretion may be accomplished with pharmacologic acid inhibition. The goal of surgical treatment should be removal of all gross tumor in those without distant metastases ...
William J. Schulte +4 more
openaire +3 more sources
Abstract Zollinger-Ellison syndrome is caused by a neuroendocrine tumor of the pancreas that secretes gastrin, causing massive gastric acid secretion. Treatment of the acid hypersecretion may be accomplished with pharmacologic acid inhibition. The goal of surgical treatment should be removal of all gross tumor in those without distant metastases ...
William J. Schulte +4 more
openaire +3 more sources
Postgraduate Medicine, 1980
The Zollinger-Ellison syndrome (ZES) is characterized by gastrin-producing tumors, gastric acid hypersecretion, peptic ulcers, and diarrhea. ZES may be associated with nonpancreatic endocrine tumors as part of the multiple endocrine adenomatosis-type 1 syndrome.
J B, Marshall, R H, Settles
openaire +2 more sources
The Zollinger-Ellison syndrome (ZES) is characterized by gastrin-producing tumors, gastric acid hypersecretion, peptic ulcers, and diarrhea. ZES may be associated with nonpancreatic endocrine tumors as part of the multiple endocrine adenomatosis-type 1 syndrome.
J B, Marshall, R H, Settles
openaire +2 more sources